ROHM Co., Ltd.
ROHM Co., Ltd. (ROHCY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for ROHM Co., Ltd. (ROHCY), covering cash flow, earnings, and balance sheets.
ROHM Co., Ltd. (ROHCY) Income Statement & Financial Overview
View the income breakdown for ROHM Co., Ltd. ROHCY across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $103.82B | $112.62B | $113.75B | $118.28B |
| Cost of Revenue | $104.27B | $94.60B | $86.66B | $88.67B |
| Gross Profit | -$449.00M | $18.02B | $27.09B | $29.60B |
| Gross Profit Ratio | -$0.004 | $0.16 | $0.24 | $0.25 |
| R&D Expenses | $12.82B | $14.66B | $15.16B | $14.60B |
| SG&A Expenses | $15.71B | $13.46B | $29.34B | $28.33B |
| Operating Expenses | $28.53B | $28.13B | $29.34B | $28.33B |
| Total Costs & Expenses | $132.81B | $122.73B | $115.99B | $117.006B |
| Interest Income | $1.65B | $2.17B | $2.15B | $1.97B |
| Interest Expense | $347.00M | $317.00M | $50.00M | $326.00M |
| Depreciation & Amortization | $21.89B | $21.20B | $20.55B | $19.76B |
| EBITDA | -$40.35B | $21.88B | $18.31B | $21.04B |
| EBITDA Ratio | -$0.39 | $0.19 | $0.16 | $0.18 |
| Operating Income | -$28.98B | -$10.11B | -$2.24B | $1.27B |
| Operating Income Ratio | -$0.28 | -$0.09 | -$0.02 | $0.01 |
| Other Income/Expenses (Net) | -$33.61B | $10.46B | -$1.40B | $7.88B |
| Income Before Tax | -$62.59B | $355.00M | -$3.65B | $9.15B |
| Income Before Tax Ratio | -$0.60 | $0.003 | -$0.03 | $0.08 |
| Income Tax Expense | -$12.32B | $2.19B | -$2.25B | $5.68B |
| Net Income | -$50.27B | -$1.86B | -$1.40B | $3.46B |
| Net Income Ratio | -$0.48 | -$0.02 | -$0.01 | $0.03 |
| EPS | -$130.32 | -$4.81 | -$3.61 | $8.97 |
| Diluted EPS | -$130.32 | -$4.81 | -$3.61 | $7.38 |
| Weighted Avg Shares Outstanding | $385.79M | $385.98M | $385.98M | $385.94M |
| Weighted Avg Shares Outstanding (Diluted) | $385.98M | $385.98M | $385.98M | $469.24M |
The company's financials show resilient growth, with revenue advancing from $118.28B in Q1 2024 to $103.82B in Q4 2024. Gross profit remained healthy with margins at -0% in Q4 2024 compared to 25% in Q1 2024. Operating income hit -$28.98B last quarter, sustaining a consistent -28% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$40.35B. Net income dropped to -$50.27B, while earnings per share reached -$130.32. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan